SCHEMBL9445988

SCHEMBL9445988

COc1ccc2nc([S+]([O-])Cc3ncc(C)c(OC)c3C)n(CCCC#N)c2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.41
CYP1A2 P05177 3/20 0.41
CYP3A4 P08684 3/20 0.41
WDR5 P61964 2/20 0.41
BRS3 P32247 2/20 0.41
CYP2C9 P11712 2/20 0.41
ATP1A1 P05023 2/20 0.41
ATP1B1 P05026 2/20 0.41
ATP1A3 P13637 2/20 0.41
ATP1B2 P14415 2/20 0.41
ATP4A P20648 2/20 0.41
ATP1A2 P50993 2/20 0.41
ATP4B P51164 2/20 0.41
ATP1B3 P54709 2/20 0.41
FXYD2 P54710 2/20 0.41
ATP1A4 Q13733 2/20 0.41
MAPT P10636 2/20 0.41
ALDH1A1 P00352 2/20 0.41
KDM4E B2RXH2 1/20 0.41
DDAH1 O94760 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6772312 0.85 KMT2A (0.45) KMT2ACYP1A2CYP3A4WDR5BRS3
SCHEMBL3046965 0.85 KMT2A (0.45) KMT2ACYP1A2CYP3A4WDR5BRS3
SCHEMBL6772475 0.85 KMT2A (0.45) KMT2ACYP1A2CYP3A4WDR5BRS3
SCHEMBL6770854 0.85 KMT2A (0.45) KMT2ACYP1A2CYP3A4WDR5BRS3
SCHEMBL9697309 0.84 BRS3 (0.40) KMT2ACYP1A2CYP3A4WDR5BRS3
SCHEMBL12021142 0.84 BRS3 (0.46) KMT2ACYP1A2CYP3A4WDR5BRS3
SCHEMBL7846721 0.83 KMT2A (0.44) KMT2ACYP1A2CYP3A4WDR5BRS3
SCHEMBL9445982 0.81 CYP2C9 (0.42) KMT2ACYP1A2CYP3A4WDR5BRS3
SCHEMBL9269042 0.81 ALDH1A1 (0.42) KMT2ACYP1A2CYP3A4WDR5BRS3
SCHEMBL6773081 0.80 KMT2A (0.43) KMT2ACYP1A2CYP3A4WDR5BRS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5215974-A Antisecretory agents for gastrointestinal disorders; water solubility, chemical stability AKTIEBOLAGET HASSLE (SE) 1993-06-01 US disclosed
EP-0279149-B1 BENZIMIDAZOLE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND A PHARMACEUTICAL COMPOSITION CONTAINING THE SAME Aktiebolaget Hässle (SE) 1992-12-30 EP disclosed
EP-0332647-A1 NEW BENZIMIDAZOLE DERIVATIVES A PROCESS FOR PRODUCTION THEREOF AND A PHARMACEUTICAL COMPOSITION CONTAINING THE SAME Aktiebolaget Hässle (SE) 1989-09-20 EP disclosed
EP-0279149-A2 Benzimidazole derivatives, process for their production and a pharmaceutical composition containing the same Aktiebolaget Hässle (SE) 1988-08-24 EP disclosed
WO-1988003921-A1 NEW BENZIMIDAZOLE DERIVATIVES A PROCESS FOR PRODUCTION THEREOF AND A PHARMACEUTICAL COMPOSITION CONTAINING THE SAME Aktiebolaget Hässle (SE) 1988-06-02 WO disclosed